Testing effectiveness (Phase 2)Study completedNCT04826172
What this trial is testing
Exploratory Study on the Safety, Tolerability, and Pharmacodynamics of IMB-1018972 in Subjects With Angina Due to Obstructive Coronary Artery Disease (IMPROVE-Ischemia)
Who this might be right for
IschemiaCoronary Artery Disease
Imbria Pharmaceuticals, Inc. 58